SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease ...

KEY + WEL as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death Compared to KEYTRUDA Mono in Certain Patients ...

By Vijay Kumar Malesu New research reveals how hypoxia-driven red blood cell adaptations may reshape glucose regulation, offering fresh insight into diabetes biology and potential therapeutic ...

In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low ...

Diabetes reversed in mice with a pill mimicking high altitude hypoxia. Scientists say red blood cells hold the key.

Study Finds Red Blood Cells Improve Glucose Tolerance at High AltitudeWhy do people living at high altitudes often have better blood sugar ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.

People living at high altitude have long been observed to develop diabetes less often than those at sea level. Scientists now say they have identified a biological explanation for the trend.

Scientists have discovered that red blood cells act as hidden glucose sponges in low-oxygen conditions, explaining why people ...